Quantitative Muscle Mri
Quantitative Muscle Mri - Related Videos
09:30
Quantitative Magnetic Resonance Imaging of Skeletal Muscle Disease
0 Views •
Cited by 8 •
2016
Neuromuscular diseases often exhibit a temporally varying, spatially heterogeneous, and multi-faceted pathology. The goal of this protocol is to characterize this pathology using non-invasive magnetic resonance imaging methods.
15:10
A Dual Tracer PET-MRI Protocol for the Quantitative Measure of Regional Brain Energy Substrates Uptake in the Rat
0 Views •
Cited by 2 •
2013
Small-animal positron emission tomography enables the assessment of the brain's two main energy substrates: glucose and ketones. In the present method, 11C-acetoacetate and 18F-fluorodeoxyglucose are injected sequentially in each animal, and their uptake is measured quantitatively in specific brain regions determined from the magnetic resonance images.
12:27
Noninvasive In Vivo Small Animal MRI and MRS: Basic Experimental Procedures
0 Views •
Cited by 9 •
2009
This work describes basic procedures of noninvasive small animal MRI and MRS in vivo.
06:06
Optogenetic Functional MRI
0 Views •
Cited by 15 •
2016
This protocol describes the steps and data analysis required to successfully perform optogenetic functional magnetic resonance imaging (ofMRI). ofMRI is a novel technique that combines high-field fMRI readout with optogenetic stimulation, allowing for cell type-specific mapping of functional neural circuits and their dynamics across the whole living brain.
08:20
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
0 Views •
Cited by 31 •
2015
Here we outline the procedure for MRI-guided repetitive transcranial magnetic stimulation to the dorsomedial prefrontal cortex as an experimental treatment for major depressive disorder.
FAQs
The main measurable properties are water content, fat fraction, relaxation times, and, in some protocols, diffusion. MRI sequences capture signal behavior related to these features, allowing the resulting values to function as objective biomarkers. Because disease processes can alter these properties, measurements may reveal tissue changes that are difficult to assess through visual inspection alone.
Changes in relaxation times can reflect altered muscle tissue characteristics, while fat fraction indicates the amount of fat within muscle. Water content and diffusion provide additional information when those measurements are included. Examining these variables together can help characterize injury, inflammation, or degeneration more comprehensively than relying on a single signal feature.
Sampling across the whole muscle provides measurements from a broader tissue volume than visual review of selected image appearances. This approach can identify subtle or distributed changes in muscle properties and produce objective values for comparison. In neuromuscular disorders, that broader assessment may support more consistent characterization of disease involvement and change over time.
Conventional MRI assessment emphasizes visual interpretation of image appearance, whereas quantitative muscle MRI adds numerical measurements derived from signal behavior. These values describe features such as water content, fat fraction, and relaxation times, creating objective biomarkers alongside the images. The combination can improve disease characterization when visual changes are subtle or difficult to compare consistently.
The examination acquires MRI data using specialized sequences designed to capture signal behavior associated with specific muscle properties. Those data are then used to quantify features such as water content, fat fraction, relaxation times, and sometimes diffusion. The resulting measurements provide structured information that can be examined across muscle tissue rather than interpreted only by visual appearance.
Its medical use is especially relevant when clinicians need objective information about muscle involvement in neuromuscular disorders, muscular dystrophies, myositis, or other conditions affecting skeletal muscle. Measurements can help characterize the tissue changes associated with these conditions and provide a basis for evaluating how muscle abnormalities differ across patients or disease states.
Repeated quantitative measurements can be used to track changes in muscle tissue properties during disease progression or treatment. Changes in water content, fat fraction, relaxation times, or diffusion may provide measurable evidence of altered tissue status when those parameters are included. This supports assessment of therapeutic outcomes and helps researchers study whether muscle abnormalities change over time.